These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 15735008)
1. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Pollock CB; Shirasawa S; Sasazuki T; Kolch W; Dhillon AS Cancer Res; 2005 Feb; 65(4):1244-50. PubMed ID: 15735008 [TBL] [Abstract][Full Text] [Related]
2. R-Ras promotes tumor growth of cervical epithelial cells. Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599 [TBL] [Abstract][Full Text] [Related]
3. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase. Scuto A; Zhang H; Zhao H; Rivera M; Yeatman TJ; Jove R; Torres-Roca JF Cancer Res; 2007 Nov; 67(21):10317-24. PubMed ID: 17974974 [TBL] [Abstract][Full Text] [Related]
4. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene. Li Y; White R Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528 [TBL] [Abstract][Full Text] [Related]
5. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells. Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809 [TBL] [Abstract][Full Text] [Related]
6. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339 [TBL] [Abstract][Full Text] [Related]
7. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. Lim KH; Counter CM Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells. Houghton JA; Ebanks R; Harwood FG; Tillman DM Clin Cancer Res; 1998 Nov; 4(11):2841-8. PubMed ID: 9829751 [TBL] [Abstract][Full Text] [Related]
9. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation. Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684 [TBL] [Abstract][Full Text] [Related]
10. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer. Jin K; Park S; Ewton DZ; Friedman E Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181 [TBL] [Abstract][Full Text] [Related]
12. Critical role of Rho in cell transformation by oncogenic Ras. Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077 [TBL] [Abstract][Full Text] [Related]
13. The new sulindac derivative IND 12 reverses Ras-induced cell transformation. Karaguni IM; Herter P; Debruyne P; Chtarbova S; Kasprzynski A; Herbrand U; Ahmadian MR; Glüsenkamp KH; Winde G; Mareel M; Möröy T; Müller O Cancer Res; 2002 Mar; 62(6):1718-23. PubMed ID: 11912145 [TBL] [Abstract][Full Text] [Related]
14. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486 [TBL] [Abstract][Full Text] [Related]
15. Colon cancer cell adhesion in response to Src kinase activation and actin-cytoskeleton by non-laminar shear stress. Thamilselvan V; Patel A; van der Voort van Zyp J; Basson MD J Cell Biochem; 2004 May; 92(2):361-71. PubMed ID: 15108361 [TBL] [Abstract][Full Text] [Related]
16. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways. Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521 [TBL] [Abstract][Full Text] [Related]
17. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras. Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells. Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418 [TBL] [Abstract][Full Text] [Related]
19. Anisomycin abrogates repression of protooncogene c-fos transcription in E1A + cHa-ras-transformed cells through activation of MEK/ERK kinase cascade. Kukushkin AN; Svetlikova SB; Amanzholov RA; Pospelov VA J Cell Biochem; 2008 Feb; 103(3):1005-12. PubMed ID: 17647273 [TBL] [Abstract][Full Text] [Related]
20. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Dow LE; Elsum IA; King CL; Kinross KM; Richardson HE; Humbert PO Oncogene; 2008 Oct; 27(46):5988-6001. PubMed ID: 18641685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]